The National Institutes of Health has awarded a University System of Maryland institute a $6 million grant to develop a vaccine for the hepatitis C virus.
The Institute for Bioscience and Biotechnology Research will conduct the grant-funded research over a five-year period. The institute is a joint research enterprise between the University of Maryland, College Park, the University of Maryland, Baltimore and the National Institute of Standards and Technology.